|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Communicable Diseases | |||||
| Infection | |||||
| Streptococcal Infections | |||||
| 2 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Gram-Positive Bacterial Infections | |||||
| 3 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||